Security key
49721T101
KIORA PHARMACEUTICALS INC - Common Shares (KPRX)
CUSIP: 49721T101
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Shares
- Total 13F shares
- 803,445
- Total 13F value
- $1,213,000
- Share change
- +803,445
- SEC-reported price per share
- $1.51
- Number of holders
- 8
- Value change
- +$1,213,000
- Number of buys
- 8
- Shares outstanding
- 4,693,697
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
8
Top holders
8
KPRX full security history
Ownership snapshot
Full 13F holder table
KIORA PHARMACEUTICALS INC SEC filings
KIORA PHARMACEUTICALS INC company facts
Broader feeds
Ownership snapshot
Top reported holders of KPRX - KIORA PHARMACEUTICALS INC - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/3
Latest evidence
02 Nov 2021
3/4/5
Highest disclosed value: $3,006,550
3 rows are not safely comparable across share classes.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $3.01M.
0 of 3 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 3
ARMISTICE CAPITAL, LLC
$3.01M
Michael P. Manzo
$58.9K
Brenda Mann
$58K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-3 of 3 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$3,006,550
785,000 shares
|
— | 30 Jul 2021 |
| Michael P. Manzo |
3/4/5
VP of Engineering
|
—
class O/S missing
|
$58,898
15,378 shares
|
— | 03 Aug 2021 |
| Brenda Mann |
3/4/5
VP of Research & Development
|
—
class O/S missing
|
$57,971
15,136 shares
|
— | 02 Nov 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
803,445
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
0
Q4 2021 holders
8
Holder diff
8
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|